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Abstract
Background: The prevalence of allergic rhinitis (AR) has increased worldwide in
recent decades. This study was conducted to investigate the prevalence of self-
reported AR and profiles of AR-related comorbidities in the adult population of
China over time.
Methods: This study surveyed residents of 18 major cities in mainland China.
Telephone interviews were conducted with study participants after sampling tar-
get telephone numbers by random digit dialing. The questions asked during tele-
phone interviews were based on those included in validated questionnaires and
focused on topics regarding AR, nonallergic rhinitis (NAR), acute/chronic rhinos-
inusitis (ARS/CRS), asthma, and atopic dermatitis (AD).
Results: During 2011, a total of 47 216 telephone interviews were conducted, and
the overall response rate was 77.5%. When compared with the AR prevalence in
11 cities surveyed in 2005, there was a significant increase in self-reported adult
AR in eight of those cities (P < 0.01). In 2011, the standardized prevalence of
self-reported adult AR in the 18 cities was 17.6%. The concentration of SO2 was
positively correlated with the prevalence of AR (r = 0.504, P = 0.033). A multiple
regression model showed that the absolute change in household yearly income
was significantly associated with the change in the prevalence of AR (R2 = 0.68),
after adjusting for PM10, SO2, NO2, temperature, and humidity. The overall
prevalences of NAR, ARS, CRS, asthma, and AD in the general population were
16.4%, 5.4%, 2.1%, 5.8%, and 14%, respectively.
Conclusion: During a 6-year period, there was a significant increase in the preva-
lence of self-reported AR in the general Chinese adult population. The incidence
of AR being accompanied by rhinosinusitis, asthma, or AD was significantly
higher among individuals having self-reported AR compared with the general
population.
Allergic rhinitis (AR) is one of the most common allergic dis-
orders and affects 10% to 40% of the population worldwide
(1). Its large prevalence produces a considerable burden on
both rhinitis sufferers and society, and negatively impacts the
quality of life for large numbers of individuals. The preva-
lence of AR in many countries has markedly increased dur-
ing the past 30 years (1). Numerous studies have shown
various associations between AR, asthma, and atopic
dermatitis (AD). For example, the ‘atopic march’ refers to a
typical progression of allergic diseases including pediatric
food allergies, eczema, and asthma before a child reaches
school age and later. AR is an important risk factor for
asthma (1) and impairs the clinical management of asthma;
however, adequate treatment of AR appears to alleviate the
severity of asthma (2). Due to their associations, the preva-
lences of AR, asthma, and AD have often been surveyed
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together in epidemiological studies (3). While epidemiological
surveys have extensively used telephone interviews to gather
information in the past, the development of randomized sam-
pling phone number techniques has made telephone-based
surveys much easier and more economical to conduct than
traditional face-to-face interviews (4, 5).
During the past decade, standardized questionnaires have
been widely used to examine the prevalences of self-reported
AR and asthma. For example, a Swedish survey reported a
28% prevalence of self-reported AR in Stockholm (6). In
2005, our group conducted the first multicenter survey of AR
in China and found self-reported AR prevalences ranging
from 8% to 21.4% in 11 Chinese central cities (4). Further-
more, when conducting a survey, a well-designed question-
naire can also be used to simultaneously gather information
concerning clinical characteristics, comorbid diseases, and
patient treatment histories, as well as disease prevalence.
China can be divided into seven geographic areas: North-
east, North, Northwest, Middle, East, South, and Southwest.
These areas display considerable differences regarding their
topography and climate, which influence the population’s
lifestyle and exposure to allergens. Eleven cities, mostly
located in middle and eastern China, as well as some major
cities in the North, Northwest, and Southwest were not
included in our previous study in 2005 (4). The urban popu-
lation of China has increased from 41.76% in 2004 to
49.95% in 2010, and the gross domestic product of China
has risen from number seven in the world in 2004 to number
two in 2010 (7). This transition in socioeconomic status may
have influenced the prevalence and morbidity of diseases (8).
Up to now, no study has examined changes in the prevalence
of AR and AR-related multiple disorders over time in the
Chinese population. Therefore, our current study was
designed to investigate trends in the prevalence of AR among
individuals who resided in mainland China between 2005 and
2011. Additionally, our survey investigated the profiles and
prevalences of nonallergic rhinitis (NAR), rhinosinusitis,
asthma, and AD in major cities representing the seven geo-
graphic regions of China.
Materials and methods
Selection of cities
Eighteen major cities in mainland China were selected in this
study. These included 11 cities from the previous study con-
ducted during 2004–2005 (4), plus seven additional new cities
(Fig. 1). The smallest and largest cities were Haikou and
Shanghai, with 2.0 million and 23 million people, respec-
tively. The 18 major cities included two main municipalities
(Beijing and Shanghai), 13 capital cities of major provinces
throughout mainland China, and three capital cities of
autonomous regions: Inner Mongolia (Hohhot), Ningxia
(Yinchuan), and Xinjiang (Urumqi). The study was designed
to include a random sample of the target population in each
of the selected cities. The study protocol was reviewed and
approved by the Ethics Review Committee of Beijing Insti-
tute of Otolaryngology.
Figure 1 Locations of the 18 major cities in mainland China
selected for inclusion in the present study. The number given for
each city represents its population (millions of inhabitants) in 2010.
Abbreviations: BJ, Beijing; CC, Changchun; CD, Chengdu; CS,
Changsha; FZ, Fuzhou; GZ, Guangzhou; HK, Haikou; HZ, Hangzhou;
H, Hohhot; KM, Kunming; NJ, Nanjing; SH, Shanghai; SY, She-
nyang; U, Urumqi; WH, Wuhan; XA, Xi’An; YC, Yinchuan; ZZ,
Zhengzhou.
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Questionnaire
The questionnaire used in the current study was similar to that
used in our previous study (4). The questions were derived
from well-validated questionnaires used in the International
Study of Asthma and Allergies in Childhood (ISAAC) (4, 9)
and the European Community Respiratory Health Survey
(ECRHS) (10); however, modifications were made to include
additional questions regarding NAR, rhinosinusitis, asthma,
and AD. The questionnaire consisted of two parts. The first
part was a screening questionnaire used to gather information
regarding the age, occupation, monthly income of the intervie-
wee, and their histories of AR, NAR, rhinosinusitis, asthma,
and AD. During the survey, each interviewee was asked the
following question: ‘In the past 12 months, have you or your
family members ever had a problem with sneezing, or a runny,
blocked or itchy nose, when you were exposed to allergens
such as seasonal pollens, dust mites, etc., and did not have a
cold or the flu?’ If the answer was ‘yes’, the interviewee was
asked 14 specific questions in the second part designed to
gather specific information regarding the duration and severity
of nasal symptoms, length of past AR history, ocular symp-
toms, self-reported allergens, treatments for AR, and response
to treatments. The criteria used to diagnose AR were consis-
tent with the ARIA guidelines (1) and AR severity and dura-
tion were classified accordingly as mild, moderate/severe,
intermittent or persistent.
Similarly, NAR was diagnosed by asking the question: ‘In
the past 12 months, have you or your family members ever
had a problem with sneezing, or a runny, blocked or itchy
nose, when exposed to cold or dry air, temperature changes,
airborne irritants, foods (especially hot and spicy foods),
alcoholic beverages, or exercise?’ (11); and chronic rhinosi-
nusitis (symptoms for > 12 weeks) or acute rhinosinusitis
(symptoms for < 12 weeks) if two or more symptoms (one of
which was nasal blockage or discharge) were reported was
diagnosed by asking the question: ‘Has your nose been
blocked; have you had nasal discharge or mucus in the
throat; have you had a pain or facial pressure; or has your
sense of smell been reduced or absent for less than 12 weeks
or more than 12 weeks during the last 12 months?’ (12, 13).
Asthma was defined as reporting ‘having ever had asthma’,
plus at least one of the following symptoms during the previ-
ous 12 months: (i) Wheezing or whistling in the chest; (ii)
Waking up with tightness in the chest, shortness of breath,
or an attack of coughing (14). AD was diagnosed by a posi-
tive response to the following question ‘Have you had an
itchy rash at any time in the past 12 months?’ (15).
Telephone number sampling and telephone interviews
A computerized random digit dialing method was used to
sample targeted telephone numbers as described previously
(4, 16). Specific details of telephone number sampling used in
this study are shown in the Online Repository.
The telephone interviews were conducted between August
and October of 2011 by trained interviewers from a company
with interviewers located in each major city in China. The
interviews were conducted using the computer-assisted tele-
phone interviews technique between 16:30 and 21:00 on week-
days and 10:00 and 21:00 on weekends and holidays. In the
telephone screening interview, the interviewee was first asked to
state their age, and only subjects aged between 16 and 65 years
were eligible to answer the subsequent questions concerning
their histories of AR, NAR, rhinosinusitis, asthma, and AD, as
well as the core interview. If the subject did not satisfy the age
criteria, an eligible family member whose self-reported age was
between 16 and 65 years was contacted to answer the questions
and allowed to complete the telephone interview.
Collection of data concerning socioeconomic status,
meteorology, and air pollution
To generally assess the association between the standardized
self-reported prevalence of AR and certain factors such as air
pollution, meteorological conditions, and socioeconomic sta-
tus in 2011, we considered the following factors: (1) indica-
tors of air pollution, including the annual mean atmospheric
content of sulfur dioxide (SO2), nitrogen dioxide (NO2), and
particulate matter with an aerodynamic diameter ≤10 lm
(PM10); (2) indicators of meteorological conditions including
the annual average relative humidity and annual average
temperature; (3) individual yearly household income as an
indicator of socioeconomic status. All data were obtained
from the National Bureau of Statistics of China (7).
Data analysis
All data were entered into the study database twice by two
independent investigators. The data were categorized and ana-
lyzed using SPSS Statistics, Version 17.0. The age-standardized
prevalences of AR in the 18 cities investigated were calculated
based on data from the 2012 Statistical Yearbook (7). Poten-
tial differences among the self-reported prevalences of AR,
NAR, rhinosinusitis, asthma, and AD in the 18 cities were
assessed using the chi-square test. A bivariable correlation
analysis was performed to assess the relationship between the
standardized prevalence of AR and various external factors,
including socioeconomic status, air pollution, and meteorolog-
ical conditions. Moreover, differences were calculated between
two time points (2011  2005) to reflect the change both in
standardized prevalence of AR and the various external fac-
tors mentioned above. A multiple linear regression (forward
method) was adapted to evaluate the correlation between the
differences for the standardized prevalence of AR and differ-
ences for the external factors in 11 cities from 2005 to 2011. A
P-value <0.05 was considered statistically significant.
Results
Telephone number sampling
A total 100 635 telephone numbers were dialed. Overall,
47 216 of these numbers (46.9%) contacted an individual
who was eligible to complete the survey, of whom 36 577
subjects (77.5%) completed the interview.
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Prevalence of self-reported AR and a comparison with 2005
results
Among the 36 577 surveyed respondents, 6483 subjects
(17.7%) reported having AR. The prevalence of self-reported
AR was <15% in Chengdu, Fuzhou, and Zhengzhou, and
>20% in Beijing, Urumqi, Shenyang, Hangzhou, Kunming,
and Shanghai. The highest and lowest prevalences of self-
reported AR were 23% (Shanghai) in eastern China and 9.8%
(Chengdu) in southwestern China, respectively. After adjust-
ment for age distribution of each city’s population, the stan-
dardized prevalence of self-reported AR ranged from 9.6%
(Chengdu) to 23.9% (Shanghai). In contrast, in 2005, only 4
of the 11 cities surveyed (Shenyang, Wuhan, Changsha, and
Urumqi) had a standardized AR prevalence >15%, while 3
cities (Beijing, Hangzhou, and Xi’an) had a standardized AR
prevalence <10%. Comparison of age-adjusted prevalence of
self-reported AR between 2005 and 2011 indicated that the
standardized prevalence of AR had significantly increased in
eight of 11 cities (P < 0.01 for Guangzhou and P < 0.001 for
Beijing and Changchun, etc.), decreased in one city (Urumqi,
P < 0.01), and not significantly altered in two cities (Wuhan
and Changsha) (Table 1 and Fig. 2).
The most commonly reported symptoms of AR were
sneezing (81.8%), rhinorrhea (60.2%), blocked nose (54.9%),
nasal itching (49.6%), ocular itching (42.9%), pharyngolaryn-
geal symptoms (35.1%), watery eyes (34.5%), ocular swelling
(19.1%), and ocular ache (17.6%).
When differentiated by severity, AR was described as mild
in >50% of cases in 14 cities, but moderate/severe in ≥50%
of cases in Zhengzhou, Fuzhou, and Changchun (Fig. S1 –
Online Repository).
Assessment of intermittent and persistent AR reported by
respondents in the 18 cities investigated indicated that a
majority (57%) of respondents reported persistent AR in
only one city (Zhengzhou), whereas a majority of respon-
dents in each of the other 17 cities surveyed reported having
intermittent AR (Fig. S2 – Online Repository). Indeed, in 12
of these cities, intermittent AR was reported by >80% of the
respondents. The self-reported allergens indicated that house
dust was the most frequently mentioned allergen (range =
31.5% of respondents in Haikou to 61.4% of respondents in
Hangzhou), followed by pollen (range = 14.8% in Urumqi to
59.6% in Wuhan), weeds (range = 4.5% in Yinchuan
to 51.2% in Changchun), fungi (range = 3.0% in Yinchuan
to 36.2% in Zhengzhou), mites (range = 2.0% in Yinchuan
and Urumqi to 31.6% in Beijing), and animal dander
(range = 2.5% in Yinchuan to 30.6% in Beijing) (Table S1 –
Online Repository).
Influence of air pollution, meteorological conditions, and
socioeconomic status on the standardized prevalence of AR
in the 18 cities
Table 2 shows data for air pollution, meteorological condi-
tions, and the socioeconomic status of interviewees in 18
cities during 2011, 11 cities during 2005, and the ratios of
change for above external factors and the standardized
prevalence of AR. Firstly, we sought to evaluate the associa-
tion between these external factors and the standardized
prevalence of AR in 2011 (Table 1). No correlation was
found between the prevalence of AR and either individual
household yearly income (r = 0.389, P = 0.11), average tem-
perature (r = 0.233, P = 0.375), or relative humidity
(r = 0.192, P = 0.445). However, the standardized preva-
lence of AR was positively correlated with the concentration
of atmospheric SO2 (r = 0.504, P = 0.033). Moreover, there
was no correlation between the prevalence of AR and other
air pollutants such as PM10 and NO2 (r = 0.009, P = 0.973
and r = 0.504, P = 0.033, respectively).
Secondly, we assessed the association between the differ-
ences for the standardized prevalence of AR and those for
the various external factors in 11 cities from 2005 to 2011 by
multiple regression analysis (Table 2). A significant multiple
regression equation could be established (F = 19.123,
P = 0.002), and the model demonstrated that the change of
standardized prevalence of AR was associated with the abso-
lute change in household yearly income (R2 = 0.68, standard-
ized coefficient b = 0.825, P = 0.002), but not with the
absolute change in PM10 (b = 0.079, P = 0.737), SO2
(b = 0.283, P = 0.142), NO2 (b = 0.330, P = 0.274), average
temperature (b = 0.214, P = 0.284), or relative humidity
(b = 0.111, P = 0.597).
Self-reported NAR, rhinosinusitis, asthma, and AD
The prevalences of self-reported NAR, rhinosinusitis, asthma,
and AD in each city are shown in Table 3. The overall self-
reported prevalences of NAR, ARS, CRS, asthma, and AD
were 16.4%, 5.4%, 2.1%, 5.8%, and 14%, respectively. After
adjusting for the age distributions of the populations, the
standardized prevalences of NAR, ARS, CRS, asthma, and
AD were 14.9%, 5.9%, 2.2%, 5.2%, and 13.2%, respectively.
Comorbidity of rhinitis, rhinosinusitis, asthma, and AD
To evaluate possible comorbidities among rhinitis, rhinosi-
nusitis, asthma, and AD, we compared the self-reported
prevalences of AR, NAR, ARS, CRS, asthma, and AD in
the total population as well as the AR, NAR, and asthma
subpopulations. The prevalences of asthma, ARS, CRS, and
AD in the AR and NAR subpopulations were significantly
higher than in the total population. Furthermore, the preva-
lences of asthma and CRS in the AR subpopulation were sig-
nificantly higher than in the NAR subpopulation (Fig. 3).
Similarly, the prevalences of AR, NAR, rhinosinusitis, and
AD in the asthma subpopulation were also higher than in
the total population (Fig. 4).
Discussion
We conducted telephone interviews to assess trends in the
prevalence of self-reported AR in 18 major cities in mainland
China during an interval of 6 years (2005–2011). To the best
of our knowledge, this is the first and most comprehensive
multicenter collaborative, large-scale epidemiological survey
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of multiple atopic disorders (AR, NAR, rhinosinusitis,
asthma, and AD) ever conducted in mainland China. Com-
pared with the survey in 2005, seven new cities were added
for this survey. This allowed us to expand our nationwide
epidemiological map to better represent the prevalence and
comorbidities of AR in various geographic regions of China.
Our results revealed an overall increase in the prevalence of
self-reported AR in most cities from 2005 to 2011, suggesting
that the prevalence of AR in mainland China has not yet
reached a plateau.
The prevalences and trend of AR shown in our studies are
not consistent with the worldwide pattern of AR prevalence.
The ECRHS examined geographic variations in the preva-
lence of nasal allergies in 15 394 adults who visited 35 medi-
cal centers in 15 countries and found AR prevalences ranged
from 11.8% in Oviedo (Spain) to 46.0% in Melbourne (Aus-
tralia) (17). Furthermore, the ISAAC found a slight world-
wide increase in the prevalence of AR among children aged
13-14 years (0.18% per year) and 6-7 years (0.17% per year),
as well as a > 20-fold variation in the prevalence of self-
reported AR among countries in the same region and
between centers in the same country (3). As our data pertain
to the most populous developing country in the world, the
etiology underlying the rapid increase in self-reported AR in
various regions of China needs to be explored. It is well
known that AR results from interactions between atopic indi-
viduals and their ambient environment. The typical Chinese
diet is characterized by the high consumption of vegetables
and a relatively low consumption of animal fat. This type of
diet can lead to a relatively low intake of n-6 fatty acids, and
a reduced risk for allergic respiratory diseases (18). There-
fore, it is speculated that the characteristic prevalence of AR
in China could be attributed to environmental factors.
It is widely recognized that China’s socioeconomic growth
has resulted in a deteriorated quality of air, as the demand
for fossil fuels has greatly increased (19, 20). Statistical year-
books show that China’s coal and oil consumption increased
from 2318.5 and 325.4 million tons, respectively, in 2005 to
3429.5 and 453.8 million tons, respectively, in 2011 (7). Sev-
eral epidemiological studies have confirmed that outdoor air
pollution created by increased fossil fuel combustion con-
tributes to both the initiation and exacerbation of allergic
diseases (21). SO2, the pollutant often related to combustion
of fossil fuels, can increase the permeability of airway
mucosa, and thus enhance the penetration of allergens and
development of allergic reactions. In our 2011 survey, SO2
concentrations were positively associated with AR preva-
lence, which is consistent with our findings in 2005 (4). More-
over, higher concentrations of atmospheric CO2 can induce
an increase in the production of pollen. This effect is particu-
larly significant in China, where 75% of total CO2 emissions
result from the burning of fossil fuels (22). To make matters
worse, the number of automobiles in China has tripled from
31 million in 2005 to 93 million in 2011 (7). These vehicles
discharge large amounts of particulate matter and thus may
contribute to an overproduction of IgE and the increased
permeability of nasal mucosa in susceptible individuals (23,
24). In this survey, multiple regression analysis showed that
the increase in prevalence of AR was associated with the
increased household yearly income. It is reported that the
rapid increase in the wealth of Chinese households has been
accompanied by sales of houses increasing from 554 mil-
lion m2 in 2005 to 1 billion m2 in 2011 (7). These factors
likely lead to increasing amounts of volatile organic com-
pounds associated with high rates of AR and respiratory
conditions (25–27). Increasing numbers of individuals who
came from small families and had only limited exposure to
respiratory infections when they were children, have now
grown into adults, and constitute a high percentage of the
general adult population. This change may contribute to
the prevalence of AR in Chinese adults to the same extent as
the hygiene hypothesis (28).
In both 2005 and 2011, the majority of surveyed individu-
als in almost all of the cities studied suffered from intermit-
tent AR, which is in accordance with a finding of 71%
subjects with intermittent AR and 29% persistent AR, in a
Figure 2 Comparisons of the standardized prevalences of self-
reported allergic rhinitis (AR) in 11 major cities between 2005 and
2011. (*P < 0.001, # P < 0.01; Table 1 shows the P-values for
comparisons between 2005 and 2011.)
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study involving six European countries (29), but in contrast
to a finding of 19% subjects with intermittent AR and 81%
persistent AR in an Italian survey (30). Additionally, with
respect to severity, 65% of individuals in our study reported
mild AR and 35% moderate/severe AR. These findings, how-
ever, are in contrast to findings from two European studies,
in which the participants reported a higher proportion of
moderate/severe AR (30, 31). Further studies need to investi-
gate whether in future years AR severity might also increase
in China. On the other hand, one study using skin prick tests
(SPTs) reported that house dust mites were the most com-
mon aeroallergen; with ~40% of patients who suffered from
asthma and/or rhinitis in northern China and nearly 70% of
patients in southern China being sensitized to dust mites
(32). In contrast, <5% of adult patients in most regions of
China were sensitized to grass or tree pollen (32). A SPTs
study of adult AR patients in Beijing by our group found
that >60% of the participants were sensitized to dust mites
and 10–20% were sensitized to grass and tree pollens (33).
However, <20% of participants in the present study reported
mites as an allergen, while >40% of the participants in most
cities reported house dust as an allergen. Moreover, 20% of
participants in >50% of the cities reported pollen and weeds
as allergens. It is likely that the differences between the find-
ings in the present study and the other studies mentioned
above may have resulted from differences in study design
and the population selected, as well as suboptimal under-
standing of allergen in the general population.
In the present 2011 study, the overall prevalence of NAR
was found to be 16.4%, which was similar to the 17.7%
prevalence of AR in the Chinese adult population. However,
this finding is not in accordance with other surveys (34).
Both monocenter and multicenter studies have found NAR
and AR prevalences ranging from 17% to 36% and 64% to
83%, respectively, with the distribution ratio of NAR and
AR in Western countries being 1 : 3 (2, 35, 36). This skewing
toward a lower proportion of NAR in Western countries sug-
gests that more studies were performed among patients seek-
ing treatment at allergy clinics than among the general
population (34). Furthermore, in the current study, the
prevalences of ARS, CRS, asthma, and AD in the general
population of China were 5.4%, 2.1%, 5.8%, and 14%,
respectively, and wide variations were found across different
regions of the country. In Sweden, Finland, and Korea, the
prevalence of doctor-diagnosed CRS ranged from 3% to 5%
(13). The GA2LEN study found asthma prevalences to be
7.1%, 6.4%, 7.6%, and 6.3% in Sweden, Netherlands, Bel-
gium, and Germany, respectively (37). With regard to comor-
bidities, both our study and previous studies have identified a
strong association between AR and asthma (5, 38). In the
present study, asthma was significantly more prevalent in the
AR population (28%) vs the NAR population (16.9%). Fur-
thermore, AR and NAR were reported more frequently in
the asthma population (38.1% and 52%, respectively), com-
pared with the total population (17.7% and 16.4%, respec-
tively). Similarly, CRS was more prevalent among AR
subjects (10.1%) than in NAR subjects (6.1%) and the total
population (2.1%). These findings are consistent with those
in most studies (39–41). Shi and colleagues (42) have recently
Figure 3 Comorbidity of self-reported asthma, acute rhinosinusi-
tis, chronic rhinosinusitis, and atopic dermatitis in the total
population, and allergic rhinitis (AR) and non-AR subpopulations
(*P < 0.001).
Figure 4 Comorbidity of self-reported allergic rhinitis, nonallergic
rhinitis, acute rhinosinusitis, chronic rhinosinusitis, and atopic der-
matitis in the total population and asthma population (*P < 0.001).
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conducted a face-to-face survey in seven Chinese cities and
also demonstrated a higher prevalence of CRS among AR
subjects than normal subjects (42).
In summary, this is the first report of a rapid increase in
the prevalence of self-reported AR across various geographic
regions of China. Furthermore, the study establishes a
nationwide map showing the prevalences of AR, NAR, rhi-
nosinusitis, asthma, and AD in China. Epidemiological cross-
sectional surveys and continuous monitoring of the dynamics
are fundamental for assessing changes in AR and its comor-
bidities, identifying risk factors influencing such trends and
providing a basis for defining new health policies. The trends
in AR prevalence and the various features of its comorbidi-
ties identified in this study suggest that China’s authorities
should act to halt this increasing challenge to public health.
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